Certain senior US House Democrats objected to the blacklisting of five Chinese-linked biotechnology companies from new federally funded research and contracts, Bloomberg News reported Sunday.
The Biosecure Act would have affected BGI Group, MGI Tech (SHA:688114), Complete Genomics., WuXi AppTec (HKG:2359, SHA:603259) and WuXi Biologics (HKG:2269), according to the report.
Jim McGovern of Massachusetts and Jamie Raskin of Maryland said there should be due process to get on and off any list that excludes companies from research funded by the US, Bloomberg wrote.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。